Tzu‐Lan Yeh
Oxford Research Group(GB)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Histone Deacetylase Inhibitors Research, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials(2017)220 cited
- → A Cell‐Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1(2014)76 cited
- → Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases(2015)41 cited
- → Non-competitive cyclic peptides for targeting enzyme–substrate complexes(2018)34 cited
- → Normal tissue radioprotection by amifostine via Warburg-type effects(2016)33 cited
- → Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors(2019)29 cited
- → Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding(2018)12 cited
- → A Fluorescent Benzo[g]isoquinoline‐Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging(2018)3 cited
- → The Clinically Used Iron Chelator Deferasirox is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases(2019)